Order Article Reprints

Maratta MG, Sparagna I, Occhipinti D, Roca L, Sgambato M, Raia S, Bianchi A, Chiloiro S, Rossi E, Rindi G, et al. Upfront Oxaliplatin–Fluoropyrimidine Chemotherapy and Somatostatin Analogues in Advanced Well-Differentiated Gastro-Entero-Pancreatic Neuroendocrine Tumors. Cancers. 2025; 17(9):1561. https://doi.org/10.3390/cancers17091561

Maratta, Maria Grazia, Ileana Sparagna, Denis Occhipinti, Luigi Roca, Margherita Sgambato, Salvatore Raia, Antonio Bianchi, Sabrina Chiloiro, Ernesto Rossi, Guido Rindi, and et al. 2025. "Upfront Oxaliplatin–Fluoropyrimidine Chemotherapy and Somatostatin Analogues in Advanced Well-Differentiated Gastro-Entero-Pancreatic Neuroendocrine Tumors" Cancers 17, no. 9: 1561. https://doi.org/10.3390/cancers17091561

Maratta, M. G., Sparagna, I., Occhipinti, D., Roca, L., Sgambato, M., Raia, S., Bianchi, A., Chiloiro, S., Rossi, E., Rindi, G., Tortora, G., & Schinzari, G. (2025). Upfront Oxaliplatin–Fluoropyrimidine Chemotherapy and Somatostatin Analogues in Advanced Well-Differentiated Gastro-Entero-Pancreatic Neuroendocrine Tumors. Cancers, 17(9), 1561. https://doi.org/10.3390/cancers17091561